ALX-1393
A selective inhibitor of the glycine transporter 1
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
ALX-1393 is a selective inhibitor of the glycine transporter 1 (GlyT1). GlyT1 is a protein that plays a crucial role in the regulation of glycine levels in the synaptic cleft of neurons. By inhibiting GlyT1, ALX-1393 increases the concentration of glycine in the synaptic cleft, which can enhance NMDA receptor function.
Mechanism of Action[edit | edit source]
ALX-1393 works by binding to the glycine transporter 1, thereby inhibiting its function. This inhibition prevents the reuptake of glycine from the synaptic cleft back into the presynaptic neuron. As a result, the concentration of glycine in the synaptic cleft increases, which can potentiate the activity of NMDA receptors. NMDA receptors are a type of glutamate receptor that play a key role in synaptic plasticity and memory.
Potential Therapeutic Uses[edit | edit source]
The modulation of glycine levels through GlyT1 inhibition has been investigated for potential therapeutic applications in various neurological disorders. These include:
- Schizophrenia: Enhanced NMDA receptor function may help alleviate some of the symptoms associated with schizophrenia.
- Cognitive disorders: By improving synaptic plasticity, ALX-1393 could potentially be used to treat cognitive impairments.
- Pain management: GlyT1 inhibitors may have analgesic properties by modulating the glycine levels in the spinal cord.
Research and Development[edit | edit source]
Research on ALX-1393 is ongoing, with studies focusing on its efficacy and safety in various animal models. Clinical trials are needed to determine its potential therapeutic benefits and any possible side effects in humans.
See also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
